Tyvense 40 mg capsules, hard

Licence status
Authorised: 31/07/2015
Active substances
Lisdexamfetamine dimesylate
Dosage Form
Capsule, hard
Licence number
PA23211/005/003
Licence holder
Takeda Pharmaceuticals International AG Ireland Branch

Product documents

Licence information

ATC code
N06BA Centrally acting sympathomimetics, N06BA12 lisdexamfetamine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2). This product contains a substance listed in Schedule 2 of the Misuse of Drugs Regulations 2017.
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
31/07/2015

Educational materials for healthcare professionals

Educational materials for patients